Given miR-548k modulating ESCC lymphatic metastasis through ADAMTS1 and KLF10-EGFR signaling, we asked the question that whether the combination of miR-548k and its effector genes can better predict survival than either molecule. This evidence concerns the gene ADAMTS1 and esophageal squamous cell carcinoma.